Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Pralatrexate in Female Patients With Previously-treated Advanced or Metastatic Breast Cancer

NCT01118624 is registered in ClinicalTrials.gov with Acrotech Biopharma Inc. as lead sponsor.

NCT NCT01118624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01118624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Pralatrexate in Female Patients With Previously-treated Advanced or Metastatic Breast Cancer
Lead sponsor
Acrotech Biopharma Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
July 31, 2012
Enrollment
22 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast tumors, cancer of the breast, human mammary carcinoma, neoplasms, breast